A putative class action targeting Rodan + Fields, LLC in California federal court could draw fresh attention to the use of prostaglandin analogs in cosmetic eyelash enhancers, an issue that has sparked FDA enforcement action in the past, as well as unfair competition suits from Latisse owner Allergan plc.
Rodan + Fields Concealed Prostaglandin Risks From Lash Boost Users – Class Action
Marketers of cosmetic lash enhancers that haven’t abandoned prostaglandin analogs in favor of peptides or botanical extracts should take heed of a proposed class action against Rodan + Fields in California’s Northern District. Plaintiffs say they would not have purchased the firm’s Lash Boost and suffered alleged adverse effects if they’d been properly informed about product risks.
